Camp4 Therapeutics Corp Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue 0.35M0.65M
Gross Profit 0.35M0.65M
Operating items
Research & Development 40.62M38.82M
Selling, General & Administrative 11.61M14.92M
Operating Expenses 52.23M53.74M
Operating Income -51.88M-53.09M
EBIT -51.88M-53.09M
Non-operating items
Interest & Investment Income 2.81M1.33M
Non Operating Income 2.59M1.30M
Net income details
EBT -49.29M-51.79M
Profit After Tax -49.29M-51.80M
Income from Continuing Operations -49.29M-51.79M
Consolidated Net Income -49.29M-51.79M
Income towards Parent Company -49.29M-51.79M
Net Income towards Common Stockholders -49.29M-51.79M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 12.69M20.16M
Shares Outstanding (Diluted Average) 0.39M4.69M
EBITDA -49.29M-51.79M